Cargando…

Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions

The initial interaction between HIV-1 and the host occurs at the mucosa during sexual intercourse. In cervical mucosa, HIV-1 exists both as free and opsonized virions and this might influence initial infection. We used cervical explants to study HIV-1 transmission, the effects of opsonization on inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Tjomsland, Veronica, Ellegård, Rada, Kjölhede, Preben, Wodlin, Ninni Borendal, Hinkula, Jorma, Lifson, Jeffrey D, Larsson, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231223/
https://www.ncbi.nlm.nih.gov/pubmed/23686382
http://dx.doi.org/10.1002/eji.201243257
_version_ 1782344406408364032
author Tjomsland, Veronica
Ellegård, Rada
Kjölhede, Preben
Wodlin, Ninni Borendal
Hinkula, Jorma
Lifson, Jeffrey D
Larsson, Marie
author_facet Tjomsland, Veronica
Ellegård, Rada
Kjölhede, Preben
Wodlin, Ninni Borendal
Hinkula, Jorma
Lifson, Jeffrey D
Larsson, Marie
author_sort Tjomsland, Veronica
collection PubMed
description The initial interaction between HIV-1 and the host occurs at the mucosa during sexual intercourse. In cervical mucosa, HIV-1 exists both as free and opsonized virions and this might influence initial infection. We used cervical explants to study HIV-1 transmission, the effects of opsonization on infectivity, and how infection can be prevented. Complement opsonization enhanced HIV-1 infection of dendritic cells (DCs) compared with that by free HIV-1, but this increased infection was not observed with CD4(+) T cells. Blockage of the α4-, β7-, and β1-integrins significantly inhibited HIV-1 infection of both DCs and CD4(+) T cells. We found a greater impairment of HIV-1 infection in DCs for complement-opsonized virions compared with that of free virions when αM/β2- and α4-integrins were blocked. Blocking the C-type lectin receptor macrophage mannose receptor (MMR) inhibited infection of emigrating DCs but had no effect on CD4(+) T-cell infection. We show that blocking of integrins decreases the HIV-1 infection of both mucosal DCs and CD4(+) T cells emigrating from the cervical tissues. These findings may provide the basis of novel microbicidal strategies that may help limit or prevent initial infection of the cervical mucosa, thereby reducing or averting systemic HIV-1 infection.
format Online
Article
Text
id pubmed-4231223
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42312232014-12-15 Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions Tjomsland, Veronica Ellegård, Rada Kjölhede, Preben Wodlin, Ninni Borendal Hinkula, Jorma Lifson, Jeffrey D Larsson, Marie Eur J Immunol Immunity to Infection The initial interaction between HIV-1 and the host occurs at the mucosa during sexual intercourse. In cervical mucosa, HIV-1 exists both as free and opsonized virions and this might influence initial infection. We used cervical explants to study HIV-1 transmission, the effects of opsonization on infectivity, and how infection can be prevented. Complement opsonization enhanced HIV-1 infection of dendritic cells (DCs) compared with that by free HIV-1, but this increased infection was not observed with CD4(+) T cells. Blockage of the α4-, β7-, and β1-integrins significantly inhibited HIV-1 infection of both DCs and CD4(+) T cells. We found a greater impairment of HIV-1 infection in DCs for complement-opsonized virions compared with that of free virions when αM/β2- and α4-integrins were blocked. Blocking the C-type lectin receptor macrophage mannose receptor (MMR) inhibited infection of emigrating DCs but had no effect on CD4(+) T-cell infection. We show that blocking of integrins decreases the HIV-1 infection of both mucosal DCs and CD4(+) T cells emigrating from the cervical tissues. These findings may provide the basis of novel microbicidal strategies that may help limit or prevent initial infection of the cervical mucosa, thereby reducing or averting systemic HIV-1 infection. BlackWell Publishing Ltd 2013-09 2013-06-25 /pmc/articles/PMC4231223/ /pubmed/23686382 http://dx.doi.org/10.1002/eji.201243257 Text en © 2013 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA Weinheim. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Immunity to Infection
Tjomsland, Veronica
Ellegård, Rada
Kjölhede, Preben
Wodlin, Ninni Borendal
Hinkula, Jorma
Lifson, Jeffrey D
Larsson, Marie
Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
title Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
title_full Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
title_fullStr Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
title_full_unstemmed Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
title_short Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
title_sort blocking of integrins inhibits hiv-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
topic Immunity to Infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231223/
https://www.ncbi.nlm.nih.gov/pubmed/23686382
http://dx.doi.org/10.1002/eji.201243257
work_keys_str_mv AT tjomslandveronica blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions
AT ellegardrada blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions
AT kjolhedepreben blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions
AT wodlinninniborendal blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions
AT hinkulajorma blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions
AT lifsonjeffreyd blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions
AT larssonmarie blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions